Churning out safer microbes for drug delivery

Nat Biotechnol. 2003 Jul;21(7):758-9. doi: 10.1038/nbt0703-758.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Animals
  • Cell Division
  • Cell Survival
  • Colitis / microbiology
  • Colitis / therapy
  • Drug Delivery Systems / methods*
  • Gene Expression Regulation, Bacterial / physiology*
  • Genetic Engineering / methods
  • Humans
  • Ileum / microbiology*
  • Interleukin-10 / genetics*
  • Interleukin-10 / metabolism*
  • Interleukin-10 / therapeutic use
  • Lactococcus lactis / cytology
  • Lactococcus lactis / genetics*
  • Lactococcus lactis / growth & development
  • Lactococcus lactis / metabolism*
  • Mutagenesis, Site-Directed
  • Probiotics / therapeutic use
  • Protein Engineering / methods*
  • Swine
  • Thymidylate Synthase / deficiency
  • Thymidylate Synthase / genetics
  • Thymidylate Synthase / metabolism

Substances

  • Interleukin-10
  • Thymidylate Synthase